78
Participants
Start Date
November 15, 2024
Primary Completion Date
December 27, 2024
Study Completion Date
December 27, 2024
ET-26HCl 0.6mg/kg group
The initial dose is 0.6 mg/kg, intravenous injection,with an additional 50% starting dose if needed (30second±5second bolus completion). Infusion time was 1minute ± 5second.
ET-26HCl 0.8mg/kg group
The initial dose is 0.8 mg/kg, intravenous injection,with an additional 50% starting dose if needed (30second±5second bolus completion). Infusion time was 1minute ± 5second.
Etomidate Injectable Product 0.3mg/kg group
The initial dose is 0.3 mg/kg, intravenous injection,with an additional 50% starting dose if needed (30second±5second bolus completion).Infusion time was 1minute ± 5second.
Guangyuan First People's Hospital, Guangyuan
Yibin Second People's Hospital, Yibin
Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital, Chengdu
Lead Sponsor
Ahon Pharmaceutical Co., Ltd.
OTHER